These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 31311394)

  • 1. Phosphodiesterase 5 Associates With β2 Adrenergic Receptor to Modulate Cardiac Function in Type 2 Diabetic Hearts.
    West TM; Wang Q; Deng B; Zhang Y; Barbagallo F; Reddy GR; Chen D; Phan KS; Xu B; Isidori A; Xiang YK
    J Am Heart Assoc; 2019 Aug; 8(15):e012273. PubMed ID: 31311394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of type 5 phosphodiesterase counteracts β2-adrenergic signalling in beating cardiomyocytes.
    Isidori AM; Cornacchione M; Barbagallo F; Di Grazia A; Barrios F; Fassina L; Monaco L; Giannetta E; Gianfrilli D; Garofalo S; Zhang X; Chen X; Xiang YK; Lenzi A; Pellegrini M; Naro F
    Cardiovasc Res; 2015 Jun; 106(3):408-20. PubMed ID: 25852085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic inhibition of cGMP-specific phosphodiesterase 5 suppresses endoplasmic reticulum stress in heart failure.
    Gong W; Duan Q; Cai Z; Chen C; Ni L; Yan M; Wang X; Cianflone K; Wang DW
    Br J Pharmacol; 2013 Dec; 170(7):1396-409. PubMed ID: 24032459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibiting Insulin-Mediated β2-Adrenergic Receptor Activation Prevents Diabetes-Associated Cardiac Dysfunction.
    Wang Q; Liu Y; Fu Q; Xu B; Zhang Y; Kim S; Tan R; Barbagallo F; West T; Anderson E; Wei W; Abel ED; Xiang YK
    Circulation; 2017 Jan; 135(1):73-88. PubMed ID: 27815373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes.
    Xiao RP; Avdonin P; Zhou YY; Cheng H; Akhter SA; Eschenhagen T; Lefkowitz RJ; Koch WJ; Lakatta EG
    Circ Res; 1999 Jan 8-22; 84(1):43-52. PubMed ID: 9915773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDE5 Inhibition Ameliorates Visceral Adiposity Targeting the miR-22/SIRT1 Pathway: Evidence From the CECSID Trial.
    Fiore D; Gianfrilli D; Giannetta E; Galea N; Panio G; di Dato C; Pofi R; Pozza C; Sbardella E; Carbone I; Naro F; Lenzi A; Venneri MA; Isidori AM
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1525-34. PubMed ID: 26964730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterologous desensitization of cardiac β-adrenergic signal via hormone-induced βAR/arrestin/PDE4 complexes.
    Shi Q; Li M; Mika D; Fu Q; Kim S; Phan J; Shen A; Vandecasteele G; Xiang YK
    Cardiovasc Res; 2017 May; 113(6):656-670. PubMed ID: 28339772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-fat diet induces protein kinase A and G-protein receptor kinase phosphorylation of β
    Fu Q; Hu Y; Wang Q; Liu Y; Li N; Xu B; Kim S; Chiamvimonvat N; Xiang YK
    J Physiol; 2017 Mar; 595(6):1973-1986. PubMed ID: 27983752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice.
    Wang L; Chopp M; Szalad A; Liu Z; Bolz M; Alvarez FM; Lu M; Zhang L; Cui Y; Zhang RL; Zhang ZG
    Neuroscience; 2011 Oct; 193():399-410. PubMed ID: 21820491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphodiesterase Type 5 Inhibitor Sildenafil Decreases the Proinflammatory Chemokine CXCL10 in Human Cardiomyocytes and in Subjects with Diabetic Cardiomyopathy.
    Di Luigi L; Corinaldesi C; Colletti M; Scolletta S; Antinozzi C; Vannelli GB; Giannetta E; Gianfrilli D; Isidori AM; Migliaccio S; Poerio N; Fraziano M; Lenzi A; Crescioli C
    Inflammation; 2016 Jun; 39(3):1238-52. PubMed ID: 27165639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphodiesterase 5 inhibition ameliorates angiotensin II-dependent hypertension and renal vascular dysfunction.
    Thieme M; Sivritas SH; Mergia E; Potthoff SA; Yang G; Hering L; Grave K; Hoch H; Rump LC; Stegbauer J
    Am J Physiol Renal Physiol; 2017 Mar; 312(3):F474-F481. PubMed ID: 28052870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PDE5 inhibitor efficacy is estrogen dependent in female heart disease.
    Sasaki H; Nagayama T; Blanton RM; Seo K; Zhang M; Zhu G; Lee DI; Bedja D; Hsu S; Tsukamoto O; Takashima S; Kitakaze M; Mendelsohn ME; Karas RH; Kass DA; Takimoto E
    J Clin Invest; 2014 Jun; 124(6):2464-71. PubMed ID: 24837433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle Damage in Systemic Sclerosis and CXCL10: The Potential Therapeutic Role of PDE5 Inhibition.
    Corinaldesi C; Ross RL; Abignano G; Antinozzi C; Marampon F; di Luigi L; Buch MH; Riccieri V; Lenzi A; Crescioli C; Del Galdo F
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GRK2 blockade with βARKct is essential for cardiac β2-adrenergic receptor signaling towards increased contractility.
    Salazar NC; Vallejos X; Siryk A; Rengo G; Cannavo A; Liccardo D; De Lucia C; Gao E; Leosco D; Koch WJ; Lymperopoulos A
    Cell Commun Signal; 2013 Aug; 11():64. PubMed ID: 23984976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the Multifaceted Potential of Sildenafil in Medicine.
    Pușcașu C; Zanfirescu A; Negreș S; Șeremet OC
    Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of PKG-1α Oxidation Suppresses Antihypertrophic/Antifibrotic Effects From PDE5 Inhibition but not sGC Stimulation.
    Nakamura T; Zhu G; Ranek MJ; Kokkonen-Simon K; Zhang M; Kim GE; Tsujita K; Kass DA
    Circ Heart Fail; 2018 Mar; 11(3):e004740. PubMed ID: 29545395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender-specific immunological effects of the phosphodiesterase 5 inhibitor sildenafil in healthy mice.
    Karakhanova S; Yang Y; Link J; Soltek S; von Ahn K; Umansky V; Werner J; Bazhin AV
    Mol Immunol; 2013 Dec; 56(4):649-59. PubMed ID: 23911424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Inhibition of cGMP phosphodiesterase 5A improves diabetic cardiomyopathy: a randomized, controlled clinical trial using magnetic resonance imaging with myocardial tagging.
    Giannetta E; Isidori AM; Galea N; Carbone I; Mandosi E; Vizza CD; Naro F; Morano S; Fedele F; Lenzi A
    Circulation; 2012 May; 125(19):2323-33. PubMed ID: 22496161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress regulates left ventricular PDE5 expression in the failing heart.
    Lu Z; Xu X; Hu X; Lee S; Traverse JH; Zhu G; Fassett J; Tao Y; Zhang P; dos Remedios C; Pritzker M; Hall JL; Garry DJ; Chen Y
    Circulation; 2010 Apr; 121(13):1474-83. PubMed ID: 20308615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pde5 Inhibition Reduced Blood Pressure and Alleviated Target Organ Damage in Chronic Intermittent Hypoxia.
    Li S; Xin Q; Yan Y; Wang X; Ai H; Que B; Gong W; Nie S
    J Cardiovasc Pharmacol; 2024 Jul; 84(1):81-91. PubMed ID: 38030140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.